Form 8-K - Current report:
SEC Accession No. 0001104659-24-057008
Filing Date
2024-05-03
Accepted
2024-05-03 16:30:47
Documents
13
Period of Report
2024-04-29
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2413391d1_8k.htm   iXBRL 8-K 27552
  Complete submission text file 0001104659-24-057008.txt   199876

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA qnrx-20240429.xsd EX-101.SCH 3024
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE qnrx-20240429_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qnrx-20240429_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tm2413391d1_8k_htm.xml XML 3634
Mailing Address 23 HATA'AS STREET KFAR SABA L3 44425
Business Address 23 HATA'AS STREET KFAR SABA L3 44425 97299741444
Quoin Pharmaceuticals, Ltd. (Filer) CIK: 0001671502 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 8-K | Act: 34 | File No.: 001-37846 | Film No.: 24913680
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)